The Daily Biotech Pulse: Novavax Retreats Amid Vaccine Issues, LumiraDx COVID Test Approved In India, Sesen Shines On Positive Bladder Cancer Review
Here's a roundup of top developments in the biotech space over the last 24 hours.
TLSA: 1H:21 Financial Update
By John Vandermosten, CFA
NASDAQ:TLSA
READ THE FULL TLSA RESEARCH REPORT
TLSA: Partnership with Precision
By John Vandermosten, CFA
NASDAQ:TLSA
READ THE FULL TLSA RESEARCH REPORT
Stifel Maintains Buy on Precision BioSciences, Raises Price Target to $26
Stifel analyst Benjamin Burnett maintains Precision BioSciences (NASDAQ:DTIL) with a Buy and raises the price target from $23 to $26.
Precision BioSciences, iECURE Ink Licensing Pact For Gene Editing Therapies
Precision BioSciences Inc (NASDAQ:DTIL) and iECURE announced a license and collaboration agreement. Under the agreement iECURE plans to advance Precision’s…
The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi’s Pemphigus Trial Disappointment, Humanigen’s COVID-19 Drug Denied Emergency Use Authorization
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Sept. 8)
Precision BioSciences And iECURE Announce License And Collaboration Agreement To Develop ARCUS-Based Gene Editing Therapies
iECURE to License Precision’s PCSK9-Directed ARCUS Nuclease and Pursue Four Gene Insertion Programs Focused on Liver Diseases; Precision Retains Rights Across All Indications Except Those Licensed to iECURE
Precision BioSciences, Tiziana Life Ink Foralumab Deal For Cancer Indications
Precision BioSciences Inc (NASDAQ:DTIL) and Tiziana Life Sciences plc (NASDAQ:TLSA) have announced an exclusive license agreement for Tiziana’s foralumab. The companies plan to…
The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Sept. 1)